Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31)P Magnetic Resonance Spectroscopy

Abnormal choline phospholipid metabolism is an emerging hallmark of cancer, which is implicated in carcinogenesis and tumor progression. The malignant metabolic phenotype is characterized by high levels of phosphocholine (PC) and relatively low levels of glycerophosphocholine (GPC) in aggressive bre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wijnen, J.P., Jiang, L., Greenwood, T.R., Cheng, M., Döpkens, M., Cao, M.D., Bhujwalla, Z.M., Krishnamachary, B., Klomp, D.W.J., Glunde, K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4162314/
https://ncbi.nlm.nih.gov/pubmed/24764256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/nbm.3106
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados